FDA Approved: EMFLAZA — Original Application (PTC Therapeutics, Inc.)

View source ↗

Summary

FDA approved EMFLAZA (deflazacort) in an original application from PTC Therapeutics for Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• EMFLAZA (deflazacort)

Snippet

ORIG AP for EMFLAZA (DEFLAZACORT)